ATE147973T1 - Druckaerosolzusammensetzung - Google Patents

Druckaerosolzusammensetzung

Info

Publication number
ATE147973T1
ATE147973T1 AT91912173T AT91912173T ATE147973T1 AT E147973 T1 ATE147973 T1 AT E147973T1 AT 91912173 T AT91912173 T AT 91912173T AT 91912173 T AT91912173 T AT 91912173T AT E147973 T1 ATE147973 T1 AT E147973T1
Authority
AT
Austria
Prior art keywords
surfactant
propellant
aerosol composition
pressure aerosol
medicament
Prior art date
Application number
AT91912173T
Other languages
English (en)
Inventor
Asit Somani
Clive Booles
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909014526A external-priority patent/GB9014526D0/en
Priority claimed from GB909014527A external-priority patent/GB9014527D0/en
Priority claimed from GB909023953A external-priority patent/GB9023953D0/en
Application filed by Fisons Plc filed Critical Fisons Plc
Application granted granted Critical
Publication of ATE147973T1 publication Critical patent/ATE147973T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Fertilizers (AREA)
AT91912173T 1990-06-29 1991-06-25 Druckaerosolzusammensetzung ATE147973T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909014526A GB9014526D0 (en) 1990-06-29 1990-06-29 Aerosol formulation
GB909014527A GB9014527D0 (en) 1990-06-29 1990-06-29 Aerosol formulation
GB909023953A GB9023953D0 (en) 1990-11-03 1990-11-03 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
ATE147973T1 true ATE147973T1 (de) 1997-02-15

Family

ID=27265168

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91912173T ATE147973T1 (de) 1990-06-29 1991-06-25 Druckaerosolzusammensetzung

Country Status (21)

Country Link
US (1) US5846521A (de)
EP (1) EP0536235B1 (de)
JP (1) JP2854974B2 (de)
AT (1) ATE147973T1 (de)
AU (1) AU8055691A (de)
BR (1) BR9106595A (de)
CA (1) CA2085884C (de)
CZ (1) CZ392592A3 (de)
DE (1) DE69124374T2 (de)
DK (1) DK0536235T3 (de)
ES (1) ES2096653T3 (de)
FI (1) FI925852A0 (de)
GR (1) GR3023065T3 (de)
HU (1) HUT63554A (de)
IE (1) IE912220A1 (de)
MX (1) MX9100008A (de)
NO (1) NO924954L (de)
NZ (1) NZ238746A (de)
PT (1) PT98133A (de)
SK (1) SK392592A3 (de)
WO (1) WO1992000061A1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776434A (en) * 1988-12-06 1998-07-07 Riker Laboratories, Inc. Medicinal aerosol formulations
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5785952A (en) * 1990-11-09 1998-07-28 Glaxo Group Limited Aerosol medicament formulation having a surface coating of surfactant
HUT67449A (en) * 1991-06-10 1995-04-28 Schering Corp Aerosol formulations containing 1,1,1,2,3,3,3-heptafluoropropane
EP0653205B1 (de) * 1991-06-10 2002-10-16 Schering Corporation Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
WO1993011744A1 (en) 1991-12-12 1993-06-24 Glaxo Group Limited Medicaments
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US5376359A (en) * 1992-07-07 1994-12-27 Glaxo, Inc. Method of stabilizing aerosol formulations
MX9304585A (es) * 1992-07-31 1994-03-31 Glaxo Group Ltd Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata.
ES2122261T3 (es) * 1993-03-17 1998-12-16 Minnesota Mining & Mfg Formulacion de aerosol que contiene un adyuvante de dispersion derivado de un ester, una amida o un mercaptoester.
ES2107203T3 (es) * 1993-03-17 1997-11-16 Minnesota Mining & Mfg Una formulacion de aerosol que contiene un adyuvante de dispersion derivado de un diol-diacido.
US5593661A (en) * 1993-03-29 1997-01-14 Henry; Richard A. Lidocaine aerosol anaesthetic
ATE233544T1 (de) * 1993-12-02 2003-03-15 Abbott Lab Aerosole als darreichungsform mit cfc-freiem treibmittel
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5635159A (en) * 1994-08-26 1997-06-03 Abbott Laboratories Aerosol drug formulations containing polyglycolyzed glycerides
US5635161A (en) * 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
WO1998034595A1 (de) 1997-02-05 1998-08-13 Jago Research Ag Medizinische aerosolformulierungen
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
GB9805938D0 (en) 1998-03-19 1998-05-13 Glaxo Group Ltd Valve for aerosol container
GB9807232D0 (en) 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
ATE283033T1 (de) 1998-07-24 2004-12-15 Jago Res Ag Medizinische aerosolformulierungen
US6475467B1 (en) * 1998-08-04 2002-11-05 Jago Research Ag Medicinal aerosol formulations
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US6451287B1 (en) 2000-05-26 2002-09-17 Smithkline Beecham Corporation Fluorinated copolymer surfactants and use thereof in aerosol compositions
AU2001290075A1 (en) 2000-09-22 2002-04-02 Glaxo Group Limited Novel alkanoic acid derivatives
WO2002053190A2 (en) 2000-12-29 2002-07-11 Advanced Inhalation Research, Inc. Particles for inhalation having sustained release properties
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
GB0125127D0 (en) 2001-10-19 2001-12-12 Glaxo Group Ltd Compounds
MXPA04005865A (es) 2001-12-19 2004-09-13 Nektar Therapeutics Suministro de aminoglucosidos a los pulmones.
DE60231428D1 (de) * 2001-12-21 2009-04-16 3M Innovative Properties Co Medizinische aerosolzusammensetzungen mit einem funktionalisierten polyethylenglykol-hilfsstoff
JP2005517701A (ja) 2002-02-13 2005-06-16 グラクソ　グループ　リミテッド 界面活性剤として使用するためのカルボン酸化合物
GB0205327D0 (en) * 2002-03-06 2002-04-17 Glaxo Group Ltd compounds
ES2449718T3 (es) 2003-08-11 2014-03-20 Glaxo Group Limited Inhalador de dosis farmacéutica medida y procedimiento relacionados con el mismo
ES2668780T3 (es) 2003-08-29 2018-05-22 Glaxo Group Limited Inhalador de dosificación farmacéutica medida y procedimientos relacionados con el mismo
PT2425820E (pt) 2007-02-11 2015-08-04 Map Pharmaceuticals Inc Método de administração terapêutica de dhe para permitir o rápido alívio das enxaquecas ao mesmo tempo que minimiza o perfil de efeitos secundários
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
EP3174522A1 (de) 2014-07-29 2017-06-07 3M Innovative Properties Company Verfahren zur herstellung einer pharmazeutischen zusammensetzung

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7708731A (nl) * 1976-08-13 1978-02-15 Montedison Spa Werkwijze voor de bereiding van nieuwe drijf- middelsamenstellingen voor aerosolen.
CA1136547A (en) * 1979-03-08 1982-11-30 Song-Ling Lin Aerosol anesthetic compositions
GB8432063D0 (en) * 1984-12-19 1985-01-30 Riker Laboratories Inc Physically modified steroids
ATE77947T1 (de) * 1987-04-09 1992-07-15 Fisons Plc Pentamidin enthaltende pharmazeutische zusammensetzungen.
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828544D0 (en) * 1988-12-07 1989-01-11 Ici Plc Chemical process
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
GB8908250D0 (en) * 1989-04-12 1989-05-24 Fisons Plc Formulations
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate

Also Published As

Publication number Publication date
JPH05507712A (ja) 1993-11-04
PT98133A (pt) 1992-04-30
MX9100008A (es) 1992-02-03
EP0536235B1 (de) 1997-01-22
CA2085884A1 (en) 1991-12-30
DE69124374T2 (de) 1997-06-19
HU9204098D0 (en) 1993-03-29
BR9106595A (pt) 1993-04-20
DK0536235T3 (da) 1997-04-14
SK392592A3 (en) 1994-07-06
IE912220A1 (en) 1992-01-01
NZ238746A (en) 1992-10-28
CA2085884C (en) 2001-12-04
HUT63554A (en) 1993-09-28
DE69124374D1 (de) 1997-03-06
US5846521A (en) 1998-12-08
CZ392592A3 (en) 1993-05-12
FI925852A (fi) 1992-12-23
EP0536235A1 (de) 1993-04-14
FI925852A0 (fi) 1992-12-23
WO1992000061A1 (en) 1992-01-09
JP2854974B2 (ja) 1999-02-10
NO924954D0 (no) 1992-12-21
ES2096653T3 (es) 1997-03-16
GR3023065T3 (en) 1997-07-30
NO924954L (no) 1992-12-21
AU8055691A (en) 1992-01-23

Similar Documents

Publication Publication Date Title
ATE147973T1 (de) Druckaerosolzusammensetzung
ES2075956T3 (es) Composiciones propelentes.
DK0918507T3 (da) Aerosolformuleringer
MY110232A (en) Binary azeotropic compositions of (cf3chfchfch2cf3) with methanol or ethanol or isopropanol.
PE30399A1 (es) Producto para pulverizar sobre el cabello
DE69418342D1 (de) Neue schaumzusammensetzungen, insbesondere zur rektalen anwendung, sowie davon erhaltene schäume
ES2145254T3 (es) Formulaciones de aerosoles que contienen flunisolida.
AU6033190A (en) Foamed aerosol preparation
BR9702102A (pt) Dispositivo pressurizado
ATE254922T1 (de) Pharmazeutische zusammensetzungen mit antimikrobieller wirkung
TW365607B (en) Nonionic foaming agent for foaming cosmetic compositions
CA2176458A1 (en) Foaming Agent for Leave-On Foaming Cosmetic Compositions
JPS51116185A (en) An aerosol composition
PT666755E (pt) Inibicao da infeccao pelo vih
MY107927A (en) Prewash cleaner compositions
ES2087036A1 (es) Pomada de accion rapida contra las varices.
RU92016480A (ru) Аэрозольные композиции, содержащие лекарственный препарат
ES2091008T3 (es) Agente para el cuidado del cabello.
IE32793L (en) Water proofing treatment
SU1788630A1 (ru) Липкий состав
MX9707807A (es) Agente generador de espuma no ionico para composiciones cosmeticas espumosas.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time